Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neutec RD is the dedicated research and development arm of the Neutec Group, a prominent pharmaceutical conglomerate based in Turkey. Operating out of the Yıldız Technical University Technopark in Istanbul, Neutec RD specializes in the formulation and development of complex generic medicines and innovative drug delivery systems. The company is particularly recognized for its leadership in respiratory health, having developed a proprietary line of dry powder inhalers (DPI) and advanced inhalation therapies under the Air brand. Beyond respiratory care, Neutec RD supports a broad portfolio encompassing cardiovascular, central nervous system, and gastrointestinal therapeutic areas. With a strong focus on intellectual property, the company is one of Turkey's top patent applicants in the life sciences sector. Neutec RD plays a critical role in the group's mission to provide high-quality, accessible healthcare solutions both domestically and in international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neutec RD.